VRTX P/B: current value, 10-year range and year-by-year history
Cash & Leverage
VRTX's p/b is lower than 65% of the last 10 years.
P/B History
VRTX P/B by year
Yearly range of VRTX’s p/b from 2016 to 2026. Over the full period it ranged from 4.8 to 22.4, averaging 9.7.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 5.6 | 6.2 | 7.0 | 6.6 |
| 2025 | 5.5 | 6.8 | 8.2 | 6.2 |
| 2024 | 5.5 | 7.1 | 8.8 | 6.4 |
| 2023 | 5.3 | 5.8 | 6.5 | 6.4 |
| 2022 | 5.6 | 6.2 | 6.9 | 5.8 |
| 2021 | 4.8 | 5.9 | 7.3 | 5.6 |
| 2020 | 6.7 | 9.5 | 12.1 | 7.2 |
| 2019 | 8.3 | 9.9 | 11.4 | 9.4 |
| 2018 | 9.7 | 17.3 | 22.3 | 9.7 |
| 2017 | 13.9 | 18.7 | 22.4 | 20.8 |
| 2016 | 14.6 | 16.9 | 19.5 | 14.9 |
Get notified when VRTX P/B crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.
Price / Book Value Per ShareMost useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.
- Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
- Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.
Is VRTX P/B High or Low Right Now?
Vertex Pharmaceuticals Incorporated's P/B is currently 6.6, which is below average relative to its 10-year historical range. The 10-year median P/B for VRTX is approximately 7.3. See all VRTX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.